期刊文献+

咪喹莫特合成工艺的改进 被引量:2

Improvement of Synthesis Procedure of Imiquimod
下载PDF
导出
摘要 以2,4-二羟基喹啉为起始原料经过硝化、氯代、胺解、硝基还原、环化、苄胺化和脱苄基等七步反应合成了目标产物咪喹莫特.通过7次循环使用硝化反应的母液使2,4-二羟基-3-硝基喹啉(Ⅱ)的平均收率达99%;在95%的乙醇中使用铁粉和盐酸还原4-(2-甲基丙胺基)-2-氯-3-硝基喹啉(Ⅳ),反应完成后添加适量的无水碳酸钾使铁的氧化物容易经过滤与产物分离,得到76%收率的4-(2-甲基丙胺基)-3-氨基-2-氯喹啉(Ⅴ).通过对各个反应条件的改进,硝化、胺解、硝基还原、环化、苄胺化反应的中间产物可不经重结晶直接用于下一步反应,简化了合成工艺,使七步反应总收率超过45%. Imiquimod was synthesized from raw material 2,4-dihydroxyquinoline via 7 reaction steps including nitration, chlorination, amination, reduction of nitro group, cyclization, benzylamination and debenzylation. The average yield of 2,4-dihydroxy-3-nintroquinoline (Ⅱ) reached 99% by reusing the mother liquid of nitration for 7 times. 4- ( 2-methylpropylamino ) -2-chloro-3-nitroquinoline (Ⅳ) was reduced to 4- ( 2-methylpropylamino ) -3-amino-2-chloroquinoline (Ⅴ) by iron powder and hydrochloric acid in 95% ethanol, anhydrous K2CO3 with proper quantity was added to the reaction mixture to make the byproduct ferric oxide easy to filtrate off from the solution of Ⅴ, the yield of Ⅴ was 76%. With the improved synthesis procedure, the intermediates obtained from the nitration, the amination, the reduction of nitro group, the cyclization and the benzylamination were pure enough to be directly used in the next reaction without further purification, thus simplifying the synthesis procedure with an overall imiquimod yield of more than 45 %.
出处 《华南理工大学学报(自然科学版)》 EI CAS CSCD 北大核心 2007年第7期78-81,共4页 Journal of South China University of Technology(Natural Science Edition)
基金 广东省重点科技攻关项目(2003C104043)
关键词 2 4-二羟基喹啉 咪喹莫特 免疫调节剂 合成 2,4-dihydroxyquinoline imiquimod immune response modifier synthesis
  • 相关文献

参考文献11

  • 1吴巧珍.咪喹莫特——一种新型免疫调节剂[J].国外医学(免疫学分册),2003,26(4):201-204. 被引量:4
  • 2Edwards L,Ferencsy A,Eron L,et al.Self-administered topical 5% imiquimod cream for external anogenital warts[J].Arch Dermatol,1998,134(1):25-30.
  • 3Garland S M,Sellors J W,Wikstrom A,et al.Imiquimod 5% cream is a sate and effective self-applied treatment for anogenital warts-results of an open-label,multicentre phase Ⅲ B trial[J].Int J STD AIDS,2001,12(11):722-729.
  • 4顾恒,曾凡钦,郭在培,彭振辉,毕志刚,朱学骏,陈昆,郭庆,张谊之,闫乎铃,张美华,韩钢文,常宝珠,刘训荃(指导),王家璧(指导).咪喹莫特乳膏治疗尖锐湿疣随机、双盲、多中心研究[J].中华皮肤科杂志,2003,36(9):501-504. 被引量:96
  • 5吴剑波,郑家润.咪喹莫特的实验室与临床研究进展[J].国外医学(皮肤性病学分册),2003,29(2):74-77. 被引量:22
  • 6Gerster J F.1H-imidazo[4,5-c]quinolin-4-amines and antiviral use:US,4689338[P].1987-08-25.
  • 7沈敬山,李剑峰,李卉君,严铁马,雷厉军,嵇汝运,王桂莉,杨直.咪喹莫特的合成研究[J].化学研究与应用,2001,13(3):249-252. 被引量:4
  • 8André J D,Lagain D.3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1-H-imidazo[4,5-c]quinolines:US,4988815[P].1991-01-29.
  • 9Nikolaides N,Lindstrom K J.Process for preparing quinoline amines:US,5395937[P].1995-03-07.
  • 10Gerster J F,Lindstrom K J.Process for preparing imidazoquinolinamines:WO,9748704[P].1997-12-24.

二级参考文献61

  • 1朱学骏,孔繁荣,季素珍,白义杰,李正刚,吴长山.尤脱欣与疣敌治疗尖锐湿疣的疗效比较[J].中华皮肤科杂志,1994,27(3):199-200. 被引量:7
  • 2杨文彪,徐广坤.CO_2激光浅表凝固法治疗外生殖器尖锐湿疣[J].中华皮肤科杂志,1994,27(3):174-174. 被引量:16
  • 3[1]Gerster JF.1H-Imidazo[4,5-c]quinolins and 1H-Imidazo[4,5-c]quinoline-4-amines[P].EP:145340,1985-06-19;Gerster JF,Minn W.1H-Imidazo[4,5-c]quinolin-4-amines and antiviral use[P].US:4689338,1987-08-25.
  • 4[2]Gerster JF.Process for the preparation of imidazo[4,5-c]quinolin-4-amines[P].WO:92/06093,1992-04-16;Process for imidazo[4,5-c]quinolin-4-amines[P].WO:92/15581,1992-09-17.
  • 5[3]Nikolaides N,Lindstrom KJ.Process for preparing quinoline amines[P].WO:94/17043,1994-08-04.
  • 6[4]Gerster JF,Lindstrom KJ.Process for preparing imidazoquinolinamines[P].WO:97/48704,1997-12-24.
  • 7[5]Yoshioka H,Matsuya Y,Choshi T,et al.Chem.Pharm.Bull.,1996,44(4):709-714.
  • 8[6]André JD,Lagain D.3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines[P].US:4988815,1991-01-29.
  • 9[7]Buckle D R,Cantello B C C,Smith H,et al.J.Med.Chem.,1975,18(7):726-732.
  • 10[8]The Merck Index:4957,1999,12:3 On CD-Room.

共引文献116

同被引文献36

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部